Atlas Trials

Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients

Clinical trial NCT04046094 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04046094
Sponsor
University of Kansas Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2019-10-17
Primary completion
2022-09-12
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.